• Brian R Englum, Kristy L Rialon, Paul J Speicher, Brian Gulack, Timothy A Driscoll, Susan G Kreissman, and Henry E Rice.
• Department of Surgery, Duke University School of Medicine, Durham, North Carolina.
• Pediatr Blood Cancer. 2015 Sep 1;62(9):1529-35.

BackgroundThe value of gross total resection (GTR) for children with high-risk neuroblastoma (NB) is controversial. We hypothesized that patients undergoing GTR would demonstrate improved overall survival (OS) compared those having MethodsUsing a single institutional database, we reviewed the medical records of all children with high-risk NB undergoing hematopoietic stem cell transplantation (HSCT) as part of multimodality therapy from 1990 to 2012. Children had received surgical care at multiple institutions (n = 14) prior to HSCT and were divided into two groups based on extent of surgical resection: GTR (no visible or palpable disease at end of operation) and ResultsOne hundred four children underwent HSCT, and 87 (83.6%) had adequate data for analysis. Thirty eight percent had GTR while 62% had 90% resection compared to <90% resection (P = 0.008). Multivariable Cox models confirmed these findings with improved survival in children undergoing >90% vs. <90% resection but no difference in GTR vs. ConclusionGross total resection prior to HSCT in high-risk NB patients is not associated with improved OS compared to 90% resection is associated with improved OS compared to less than 90% resection.© 2015 Wiley Periodicals, Inc.

46 keywords...

hide…